A new USC Schaeffer white paper shows how
#PBM accounting practices and mergers with other players in the pharmaceutical supply chain obscure where profits are generated.
PBM Profits Obscured by Mergers and Accounting Practices, USC Schaeffer White Paper Shows - January 22, 2026 - USC Schaeffer
PBMs' slim profit margins may be strongly influenced by their accounting practices, and widespread industry consolidation has made assessing PBM profitability more difficult. - January 22, 2026
